Significantly upregulated serum tRF-Leu-CAG was associated with stage progression for NSCLC, and may be involved in regulating AURKA to promote cell proliferation and cell cycle in NSCLC [138]. The gene discussed is AURKA; the disease is non-small cell lung carcinoma.